AGP Executive Report
Last update: 7 hours agoMorocco’s CBD Medicine: Pharma 5 says it has developed the country’s first cannabis-based medicine, using CBD purified to more than 98% to treat severe epilepsy that resists conventional drugs. The company says it controls production from regulated cultivation to manufacturing. Hemp Rules Tighten: New U.S. federal restrictions took effect Nov. 12, with further limits due Dec. 11 that could sharply narrow the market for hemp-derived products. Businesses warn the changes threaten their operations. Australia’s Market Outlook: A new report forecasts the medical cannabis market will grow from $782 million in 2025 to $2.67 billion by 2035; hemp-based products account for 54% of the market. CBD Retail: Japanese chain CHILLAXY has opened two new CBD shops in Tokyo, in Kabukicho and Ikebukuro.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.